MX2007004120A - Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente. - Google Patents

Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.

Info

Publication number
MX2007004120A
MX2007004120A MX2007004120A MX2007004120A MX2007004120A MX 2007004120 A MX2007004120 A MX 2007004120A MX 2007004120 A MX2007004120 A MX 2007004120A MX 2007004120 A MX2007004120 A MX 2007004120A MX 2007004120 A MX2007004120 A MX 2007004120A
Authority
MX
Mexico
Prior art keywords
methods
extended cycle
dose extended
hormonal treatment
treatment utilizing
Prior art date
Application number
MX2007004120A
Other languages
English (en)
Inventor
Lance J Bronnenkant
Kathleen Z Reape
Charles E Diliberti
Original Assignee
Duramed Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duramed Pharmaceuticals Inc filed Critical Duramed Pharmaceuticals Inc
Publication of MX2007004120A publication Critical patent/MX2007004120A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion proporciona regimenes de ciclo prolongado de dosis ascendente en los cuales una mujer es administrada con un estrogeno y una progestina durante un periodo mayor que 30 o 31 dias consecutivos, seguido opcionalmente por un periodo libre de hormonas o por un periodo de administracion de estrogeno. Los regimenes descritos pueden ser administrados a una mujer para proporcionar beneficios contraceptivos y no contraceptivos.
MX2007004120A 2004-10-07 2005-10-07 Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente. MX2007004120A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61642404P 2004-10-07 2004-10-07
US68456805P 2005-05-26 2005-05-26
PCT/US2005/035997 WO2006042021A2 (en) 2004-10-07 2005-10-07 Methods of hormonal treatment utilizing ascending-dose extended cycle regimens

Publications (1)

Publication Number Publication Date
MX2007004120A true MX2007004120A (es) 2007-06-15

Family

ID=36001184

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007004120A MX2007004120A (es) 2004-10-07 2005-10-07 Metodos de tratamiento hormonal utilizando regimentes de ciclo prolongado de dosis ascendente.

Country Status (11)

Country Link
US (1) US20060135496A1 (es)
EP (3) EP2392332A1 (es)
JP (1) JP2008515909A (es)
AR (1) AR051931A1 (es)
AU (1) AU2005294269B2 (es)
BR (1) BRPI0516247A (es)
CA (1) CA2582530A1 (es)
IL (1) IL182287A0 (es)
MX (1) MX2007004120A (es)
TW (1) TW200626161A (es)
WO (1) WO2006042021A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032756A1 (en) * 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
WO2003049744A1 (en) 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
RU2308954C2 (ru) * 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
WO2005007112A2 (en) * 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
DE102004019743B4 (de) * 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8153616B2 (en) * 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
KR20090029237A (ko) 2006-06-02 2009-03-20 피어 트리 파머슈티칼스 인코포레이티드 위축성 질염을 치료하는 방법
EP1930010A1 (de) * 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US8828981B2 (en) * 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN101636166B (zh) * 2007-02-06 2013-04-10 哥伦比亚实验室(百慕大群岛)有限公司 用于预防早产的孕酮
CA2740005C (en) 2008-10-08 2016-11-01 Agile Therapeutics, Inc. Transdermal delivery
US9192614B2 (en) 2008-10-08 2015-11-24 Agile Therapeutics, Inc. Contraceptive transdermal delivery of hormones
WO2010042607A1 (en) 2008-10-08 2010-04-15 Agile Therapeutics, Inc Transdermal delivery
EP2410859A4 (en) 2009-03-27 2013-03-13 Agile Therapeutics Inc TRANSDERMAL ADMINISTRATION

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4544554A (en) * 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) * 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US5010070A (en) * 1987-06-15 1991-04-23 Warner-Lambert Company Graduated estrogen contraceptive
US4962098A (en) * 1987-06-15 1990-10-09 Warner-Lambert Company Graduated estrogen contraceptive
DK174724B1 (da) 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
US5747480A (en) * 1996-05-08 1998-05-05 American Home Products Corporation Oral contraceptive
US5858405A (en) * 1996-07-26 1999-01-12 American Home Products Corporation Oral contraceptive
AU3888597A (en) * 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6251956B1 (en) * 1998-08-20 2001-06-26 Ortho Pharmaceutical Corporation Combination progestin oral contraceptive regimen
US6214815B1 (en) * 1998-12-23 2001-04-10 Ortho-Mcneil Pharmaceuticals, Inc. Triphasic oral contraceptive
US7297688B2 (en) * 2000-06-08 2007-11-20 Wyeth Starter kit for low dose oral contraceptives
WO2003049744A1 (en) * 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US20030219471A1 (en) * 2002-03-11 2003-11-27 Caubel Patrick Michel Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
WO2003084547A1 (en) * 2002-04-03 2003-10-16 Barr Laboratories, Inc. Step-down estrogen therapy
EP1624848A4 (en) * 2003-05-02 2009-02-25 Duramed Pharmaceuticals Inc METHOD FOR HORMONY TREATMENT WITH CONTRAZEPTVA SCHEMATES WITH EXTENDED CYCLE
WO2005007112A2 (en) * 2003-07-16 2005-01-27 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
EP1673094A1 (en) * 2003-10-01 2006-06-28 Janssen Pharmaceutica N.V. Extended triphasic contraceptive regimens
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens

Also Published As

Publication number Publication date
EP2392332A1 (en) 2011-12-07
WO2006042021B1 (en) 2006-08-03
WO2006042021A3 (en) 2006-06-08
WO2006042021A2 (en) 2006-04-20
EP1814556A2 (en) 2007-08-08
JP2008515909A (ja) 2008-05-15
TW200626161A (en) 2006-08-01
AU2005294269B2 (en) 2011-07-28
BRPI0516247A (pt) 2008-08-26
CA2582530A1 (en) 2006-04-20
AR051931A1 (es) 2007-02-21
EP2392333A1 (en) 2011-12-07
US20060135496A1 (en) 2006-06-22
IL182287A0 (en) 2008-04-13
AU2005294269A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
TW200626161A (en) Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
WO2005007112A3 (en) Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
WO2004098517A3 (en) Methods of hormonal treatment utilizing extended cycle contraceptive regimens
TW200603813A (en) Cyclic progestin regimens and kits
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
MX347237B (es) Formulaciones farmaceuticas y usos de las mismas en el tratamiento de la disfuncion sexual femenina.
EG25822A (en) Quinolinyl-pyrrolopyrazoles
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
NO20080824L (no) Oral prevensjon med trimegeston
TW200602063A (en) Compositions and methods for treatment of premenstrual dysphoric disorder
AR054144A1 (es) Regimenes para anticonceptivos monofasicos orales
CR8010A (es) Regimenes de contraceptivos transdermicos extendidos
IL166596A0 (en) Salt of morphine-6-glucoronide
WO2005011618A3 (en) Methods for the treatment of male and female sexual dysfunction
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
MY136880A (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
TW200518778A (en) Shampoo composition
CY1111406T1 (el) Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης
WO2003099322A3 (en) Il-11 derivatives and therapeutic uses thereof
WO2008005333A3 (en) Use of extended cycle and continuous estrogen contraceptive regimens in the treatment of osteopenia and related conditions in adolescent females
WO2006017491A3 (en) Methods and compositions to reduce tissue irritation in parenteral formulations
UA93755C2 (uk) Засіб, що проявляє ноотропну активність, має антихолестеразну дію, відновлює та стимулює нервово-м`язову передачу
MD3120F1 (en) Method of influenza prophylaxis
MD1780F1 (en) Method of treatment of patients with hepatic cirrhosis

Legal Events

Date Code Title Description
HC Change of company name or juridical status

Owner name: AMERICAN STERILIZER COMPANY

FA Abandonment or withdrawal